Israeli start-up Future Meat has claimed a huge leap towards commercial viability for its lab-grown chicken, slashing production costs by almost half in just a few months.
The company, whose backers include Archer Daniels Midland, Tyson Foods and S2G, said it was now producing a 110 gramme chicken breast for just under $4, down from $7.50 announced at the start of the year.
Rom Kshuk, chief executive, said he expected the cost to fall to below $2 in the next 12-18 months.
您已阅读15%（474字），剩余85%（2773字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。